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P
atients with acute type A aortic dissection (ATA-AD) presenting with organ necrosis and failure because of dissection-related malperfusion (malperfusion syndrome [MPS] ) have a worse prognosis with operative mortality ranging between 25% and 45%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Classic teaching 1, 4, 17, 18 predicates that every patient with ATAAD (even with MPS) be treated with immediate aortic repair to prevent death from aortic rupture, with the assumption that stabilizing the true lumen through aortic repair resolves the peripheral organ malperfusion. However, end-organ failure from MPS might be the most immediate life-threatening problem for relatively stable patients presenting with no evidence of aortic rupture or tamponade. Moreover, malperfusion because of static obstruction of branch vessels (such as thrombosis) may not be resolved by open aortic repair alone. 19, 20 In 1996, the University of Michigan adopted a new paradigm of care for patients with MPS ( Figure 1) , 21 entailing upfront percutaneous endovascular revascularization through fenestration and/or stenting of the critically malperfused abdominal organs or extremities by interventional radiology (IR), followed by delayed open repair (OR) of the dissected proximal aorta. In 2008, we reported outcomes from the first decade (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) and found a significant improvement in operative mortality of patients with ATAAD and MPS. 22 Other centers have subsequently adopted similar strategies to treat patients with MPS. 11, [23] [24] [25] [26] [27] However, a staged approach puts patients at risk for aortic rupture while awaiting resolution of malperfusion-related organ failure before OR. Over the last decade, we continued to modify our strategy to improve clinical outcomes.
In this study, we focus on the modifications in our strategy and outcomes in the second decade (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) . We hypothesized that the observed mortality would be lower than the expected mortality after an "upfront surgical repair for every ATAAD patient" approach, according to prognostic models from the literature.
METHODS
The deidentified data, analytic methods, and study materials will be made available to other researchers for the purposes of reproducing the results or replicating the procedure at Michigan Medicine.
Clinical Perspective
What Is New?
• All patients with acute type A aortic dissection are traditionally managed with emergent open aortic repair, including those with malperfusion syndrome (MPS), end-organ necrosis, and failure because of malperfusion.
• For 2 decades, we have treated relatively stable patients with visceral or extremity MPS with endovascular reperfusion through fenestration/stenting first followed by delayed open aortic repair. • In the second decade, the in-hospital mortality of all comers was 11%.
• The 30-day operative mortality utilizing this approach for patients with MPS was 3.7%, which was significantly lower than the expected mortalities with upfront open repair for every patient models in the literature.
What Are the Clinical Implications?
• Patients with acute type A aortic dissection complicated by visceral or extremity MPS but without aortic rupture or cardiac tamponade have a greater risk of dying from organ failure than from aortic rupture.
• Percutaneous endovascular fenestration/stenting of the aorta and branch vessels can quickly and completely revascularize the obstructed arteries with less trauma and a low risk of aortic rupture.
• This approach provides borderline patients the opportunity to recover and improve short-and long-term survival, and it prevents a futile open aortic repair in the presence of unsalvageable organ damage and failure.
• This approach could change the algorithm for treating patients with acute type A aortic dissection and MPS. 
Patient Population
This study was approved by the Institutional Review Board at the University of Michigan. All patients (n=602) who presented to the University of Michigan with an ATAAD (defined as onset in ≤14 days of admission) between July 1996 and January 2017 were identified. Four patients received no form of intervention (ie, endovascular fenestration/stenting or OR): 2 patients died after presentation to the emergency department, 1 patient presented with severe multiorgan failure and refused further intervention, and 1 patient suffered a massive hemorrhagic stroke and received palliative measures until demise. One patient underwent successful thoracic endovascular aortic repair of a retrograde ATAAD. Therefore, 597 patients were included in the analysis, including 243 patients from the first decade (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) and 354 patients from the second decade (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) .
We obtained Society of Thoracic Surgeons data elements from the University of Michigan Cardiac Surgery Data Warehouse to identify the cohort and determine pre-, intra-, and postoperative characteristics. The National Death Index database through December 31, 2015, and medical record review were utilized to collect information about survival and other information found in the online-only Data Supplement.
Definition of MPS
We defined malperfusion as inadequate blood flow to the end organs because of dissection-related obstruction of the aorta and its branches and MPS as tissue necrosis and functional failure of vital organs (such as viscera or lower extremity) secondary to late-stage malperfusion. The diagnosis of MPS requires both clinical features and laboratory findings (eg, abdominal pain and tenderness to palpation, decreased urine output, elevated lactate, liver or pancreatic enzymes, bilirubin or creatinine, absence of peripheral pulses, motor or sensory deficit of the extremity, neurological deficit) compatible with end-organ failure as well as radiographic findings demonstrating dynamic or static findings consistent with low or absent blood flow to the damaged end organs. Patients diagnosed with visceral and/or extremity MPS were considered candidates for endovascular fenestration/stenting unless there was an aortic rupture or cardiac tamponade.
Indications for IR Procedures
The following indications for angiographic evaluation of patients for endovascular fenestration/stenting in IR are clinical evidence of tissue/organ necrosis and dysfunction (MPS), not just malperfusion of branch vessels on imaging: (1) celiac artery malperfusion on CT angiogram, abdominal pain, and increased liver enzymes; (2) superior mesenteric artery (SMA) malperfusion on CT angiogram, abdominal pain, bloody diarrhea, or increased serum lactate and metabolic acidosis; and (3) iliac or femoral artery malperfusion on CT angiogram, loss of sensation and motor function of extremities, and loss of radial or femoral pulse with or without increased serum lactate or creatinine kinase. Frequently, patients have multiple vascular beds of malperfusion. As long as there is suspected MPS of any end organ (necrosis and dysfunction of the organ), we perform fenestration/stenting first. Isolated renal MPS used to be an indication but not in current practice. Isolated coronary artery, cerebral, and spinal cord MPS in ATAAD were not indications for IR and were treated with emergent open aortic repair. It should be noted that, unlike leg malperfusion, where physical examination is available, or renal malperfusion, where abnormal renal enhancement suggests possible renal malperfusion, SMA malperfusion can be relatively hard to diagnose until hours after onset. The indications for angiographic treatment of patients with ATAAD with fenestration/ stenting during the IR procedure were angiographic, intravascular ultrasound, and manometric evidence for ongoing arterial obstruction.
Over 2 decades, of 597 patients with ATAAD, 419 presented without MPS and 178 presented with MPS ( 
Endovascular Fenestration/Stenting (IR Procedures)
All fenestration/stenting was performed percutaneously in the angiography suite or hybrid room at the University of Michigan. Angiographic confirmation of treatable MPS was documented by a significant pressure gradient (>15 mm Hg) between the ascending aorta true lumen and a branch artery. Fenestration and stenting were performed percutaneously by creating a tear in the dissection flap to equalize the blood pressure (BP) and permit flow between the true and false lumens as previously described. 21, 22 Fenestration was most frequently created above the celiac artery for visceral malperfusion and below the lowest renal artery for iliac artery malperfusion. We measured the BP of the malperfused portion of the aorta or aortic branches before (baseline BP) and after fenestration/stenting of the aorta or aortic branches (completion BP). Selective branch arteriography (and, if necessary, intravascular ultrasound inspection) was performed in the SMA, renal, and iliac arteries to confirm branch artery obstruction, localize the terminal extent of a branch artery dissection, and distinguish between true and false lumen thrombus. Branch artery pressure was measured just past the vessel origin of undissected arteries or in the distal undissected segment of dissected vessels. The time between baseline and completion BP was noted as the time needed for the intervention. Treatment of dynamic visceral artery obstruction began with fenestration slightly above the celiac origin, and then a 16-to 18-mm Wallstent was deployed in the aortic true lumen such that it extended down to the rostral margin of the SMA. This procedure resolved dynamic obstruction of the celiac artery, SMA, and sometimes the renal arteries. Based on our experience in the second decade, the average time to perform aortic fenestration/stenting to resolve dynamic malperfusion was 30 minutes.
If, after correction of dynamic obstruction by aortic fenestration/stenting, the pressure gradient between the ascending aorta and a dissected branch vessel, such as the SMA, was 
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still >15 mm Hg, bare stents were placed into the true lumen of the branch vessel down past the terminal extent of the dissection. In dissected vessels with thrombosed false lumens, gradients after stenting might be >15 mm Hg. However, as long as absolute perfusion pressure was viable (ie, >60 mm Hg), postdilation of stents was not performed. In nondissected branch arteries, gradients persisting after proximal aortic fenestration and stenting usually indicate persistent dynamic obstruction, which generally respond to infrarenal aortic fenestration and aortoiliac stenting. Thrombolysis, thrombectomy, and embolectomy were occasionally performed to resolve thrombus in the true lumen of branch arteries, typically because of stasis distal to an obstructing flap or thrombosed false lumen. Renal artery stenting takes ≈40 minutes and infrarenal aortic fenestration and aortoiliac stenting ≈90 minutes. Clearing SMA true lumen thrombus distal to an obstructing proximal SMA false lumen thrombosis takes 3 hours for tissue plasminogen activator thrombolysis and SMA stenting. Celiac artery stenting, which takes 60 minutes on average, is rarely necessary. We only study and treat the celiac trunk if the SMA is extensively dissected or if the liver enzymes are grossly elevated.
In those 135 patients with ATAAD with suspected visceral and/or extremity MPS, 3 (2.2%) had only fenestration of the aortic dissection flap, 2 (1.5%) had only aortic true lumen stenting, 11 (8%) had both fenestration and stenting of the aorta alone, 13 (9.6%) had fenestration/stenting of the aortic branch vessels alone without aortic intervention, and 83 (61%) had aortic fenestration/stenting plus fenestration/stenting of aortic branches. Seventeen (13%) patients had additional procedures for false lumen thrombosis of aortic branch vessels (thrombolysis, thrombectomy/embolectomy, coil embolization of iliac artery aneurysm) (see Table I in the online-only Data Supplement for more details of IR procedures).
In terms of treatment order, iliac artery occlusion with a thrombosed true lumen received the highest priority. The reasoning behind this decision was that correcting dynamic obstruction before removing true lumen thrombus could result in inadvertent showering of the thrombus distally to the legs. Therefore, true lumen thrombus was aspirated first. 
Second-level priority was given to SMA obstruction, third to renal obstruction, and fourth to other extremity obstruction.
Delayed Open Aortic Repair
After patients recovered from organ failure or shock and could tolerate an open aortic operation, they underwent delayed OR. In general, in the second decade, we waited for downtrending rather than normalization of ischemic markers. For celiac (ie, hepatic) MPS, we waited for liver function tests to improve. For mesenteric MPS, we waited for recovery from bowel resection; resolution of shock, sepsis, or acute respiratory distress syndrome; and near normalization of serum lactate. For isolated renal MPS, we performed OR in ≤24 hours after the IR procedure (it is important to note that there was only 1 isolated renal MPS in the second decade).
For extremity MPS, we waited for patients to recover from shock, acidosis, acute respiratory distress syndrome, amputation if needed, and rhabdomyolysis. Most of these patients developed concomitant renal failure because of extremity MPS, but we did not wait for resolution of the renal failure before proceeding with OR. In the second decade, our vascular surgery colleagues took a more aggressive stance toward performing fasciotomies of ischemic extremities immediately after the IR procedure to relieve-or prevent-compartment syndrome and to assess viability of the muscle. If the muscle was nonviable, then we waited for patients to recover from debridement of necrotic muscle or amputation. The operative strategy was similar in both immediate OR and delayed OR groups. Our observed short-term (in-hospital or 30-day) mortality was compared with expected mortality after an upfront OR for every patient approach as determined by several prognostic models previously published in the literature:
Verona For the Penn and GERAADA models (both predicting risk of mortality in ≤30 days after surgery), we used our observed mortality after first intervention (IR or OR, whichever occurred first).
Statistical Analysis
All analyses were performed using the open source software for statistical computing and graphics R (https://www.r-project.org/) and SAS 9.4 (SAS Institute, Cary, NC). χ-square or Fisher exact test was used for categorical data. Wilcoxon ranksum test was used for nonparametric comparisons of continuous variables. Kaplan-Meier method and log-rank test were used for survival analysis. A competing risks model 31, 32 was used to analyze eventual outcome (survival without OR versus death from aortic rupture versus death from organ failure versus survival to OR) in patients after IR. We used the associated hazard ratio to compare the risk of death from aortic rupture versus death from organ failure and the proportional hazard assumption was tested using Schoenfeld residuals. Statistical significance was set at P≤0.05.
RESULTS

Short-Term Outcomes: Second Decade Versus First Decade
Patient Population and Distribution of MPS
In this study, we analyzed the outcome of all patients with ATAAD who came to our institution and were treated with either IR or OR, including all comers with celiac, mesenteric, renal, or extremity MPS, which were IR-amenable (ie, suitable for correction by endovascular techniques) ( Figure (Table) . In the second decade, there were 4 isolated mesenteric MPS cases, 1 isolated renal MPS case, and 6 isolated extremity MPS cases. Thirty-five patients had MPS of multiple vascular beds. There were nearly 3 times fewer nontherapeutic IR procedures (only diagnostic IR procedures, no arterial obstruction found) in the second decade compared with the first decade (8% versus 22%, P=0.055) (Table) .
Overall In-Hospital Mortality
Patient demographics, comorbidities, and clinical condition on admission were similar between the 2 decades (Figure 2 ).
In-Hospital Mortality of Patients With MPS Treated With Upfront IR in the Second Decade
Compared with the first decade, there was an absolute but nonsignificant 8% reduction in in-hospital mortality of patients with MPS treated with IR first (Figure 3 ). However, in the second decade, the mortality from aortic rupture significantly decreased from 16% to 4% (P=0.05) (Figure 3) , and the risk of aortic rupture was ≈7 times lower than the risk of death from organ failure (Figure 4 ). In the second decade, in patients suspected to have MPS who were treated with upfront IR, 87% of the mortality was attributable to organ failure because of complications from MPS after the arterial obstruction was resolved with fenestration/stenting (Figures 3 and  4) . The operative mortality was 43% for unstable patients with ATAAD and MPS (n=7) and 3.8% for patients undergoing IR plus delayed OR (n=26). The in-hospital mortality of all patients with MPS in the second decade (n=69) was 29%, including patients treated with IR first or OR first (unstable patients and patients with cerebral, spinal, or coronary MPS). There were no complications from the IR procedure, except for 1 patient whose aorta ruptured and died during access for the IR procedure. We divided all patients with MPS treated with IR first over 2 decades into a high-risk group (celiac/mesenteric MPS, n=84) and a low-risk group (nonceliac/mesenteric MPS, n=51). Compared with the first decade (n=54), inhospital mortality decreased from 44% to 33% in the second decade (n=30) for the high-risk group (P=0.32) and from 34% (n=32) to 32% (n=19) for the low-risk group (P=0.84). There was also no significant difference in the in-hospital mortality between the high-and lowrisk groups for the whole cohort over 2 decades (40% versus 33%, P=0.41) or in the second decade (33% versus 32%, P=0.90).
Operative Outcomes After OR
For all patients who underwent OR, there was no significant difference in the incidence of perioperative myocardial infarction, stroke, postoperative acute kidney injury, or 30-day mortality (8.0% versus 5.4%) between the 2 decades (Tables III and IV in the online-only Data Supplement).
Short-Term Outcomes: Fenestration/ Stenting Plus Delayed OR Versus Upfront OR
Our observed in-hospital mortality of all patients with ATAAD and patients without MPS was significantly lower than the expected mortality calculated from the Verona, Leipzig-Halifax, and Stockholm models (observed/ expected ratio, 0.33-0.69) ( Figure 5 ). The same observation regarding 30-day mortality was found using the Penn and GERAADA models (observed/expected ratio, 0.38-0.69) (Figure 6 ). The observed in-hospital mortality of patients with MPS treated with IR and delayed OR was significantly lower than the expected mortality calculated by the Verona model (observed/expected ratio, 0.60) ( Figure 5 ). The observed in-hospital mortality (3.8%) or 30-day mortality (3.8%) of patients who had 
Long-Term Survival of Patients With ATAAD With or Without MPS
The long-term survival of all patients with ATAAD significantly improved in the second decade ( Figure 7A 
DISCUSSION
We present a 20-year experience managing patients with ATAAD and MPS by performing upfront endovas- 33, 34 with a focus on the second decade (2008-2017). Our approach was based on the following hypotheses for a selected subset of patients with MPS: (1) the immediate risk of dying from organ failure because of MPS is higher than that from aortic rupture; and (2) endovascular reperfusion (through fenestration/stenting) as an upfront intervention is more beneficial than an upfront open aortic repair. 21 Compared with the first decade, the principal improvement in in-hospital mortality was the decrease in mortality from aortic rupture from 16% to 4% in the second decade (Figures 3 and 4) . Ninety-six percent of patients either survived to discharge or underwent delayed OR (69.5%) or died from end-organ failure (26.5%) before delayed OR (Figures 3 and 4) . Even after the branch arterial obstruction was resolved with fenestration/stenting, the risk (hazard ratio) of dying from end-organ failure was ≈7 times higher than the risk of aortic rupture. These findings support our first hypothesis that for patients with ATAAD and MPS but without aortic rupture or cardiac tamponade, the risk of dying from organ failure because of MPS is higher than the risk of dying from aortic rupture. The premise of our approach is that not every untreated ATAAD will rupture, but every untreated MPS will result in death. For isolated renal MPS, we recommend upfront open aortic repair instead of fenestration/stenting by IR because renal MPS is less life-threatening. However, frequently, renal MPS occurs in combination with other sites of malperfusion. We recommend IR evaluation if patients continue to show evidence of malperfusion after OR. It should also be noted that unsuspected SMA obstruction was frequently found in conjunction with evaluation of suspected renal or leg malperfusion. In addition, the efficacy of hypothermia for hypoxic relief of a statically or even dynamically obstructed SMA or iliac artery has not been established.
Three primary modifications in our management strategy in the second decade contributed to a lower incidence of aortic rupture between IR and OR. First, we were more selective in routing patients to IR. Over time we learned to clearly differentiate between malperfusion and MPS. We consider malperfusion to be inadequate blood flow to an end organ resulting in ischemia but not necessarily necrosis, as might follow from branch arterial obstruction as a result of the dissection, severe aortic insufficiency, pump failure from coronary artery dissection, or tamponade. In the case of branch artery obstruction, the end organ could be ischemic but not necrotic, especially at an early stage. MPS, however, ORIGINAL RESEARCH ARTICLE is late-stage malperfusion characterized by cell/tissue/ organ death and malfunction, such as necrotic bowel from mesenteric malperfusion or necrotic muscle from extremity malperfusion. In the second decade, we sent only patients with suspected MPS because of branch artery obstruction to IR first, and 45 out of 49 patients (92%) had confirmed malperfusion based on the BP gradient and had fenestration/stenting of the aorta or branch vessels. Four of 49 (8%) patients had nontherapeutic arteriography because of resolution of dynamic malperfusion from new reentry tears or BP control (Table, Figure II in the online-only Data Supplement. 19, 20, 22 The dynamic malperfusion still caused organ damage (MPS) based on the clinical assessment before its resolution. Furthermore, only 1 patient with ATAAD has undergone nontherapeutic IR since 2012 ( Figure II in the online-only Data Supplement).
Malperfusion with dynamic obstruction that is medically corrected with no end-organ damage should be treated with immediate OR to prevent aortic rupture. Static obstruction prevents the delivery of effective blood flow to the affected arterial bed and is not reliably relieved by proximal aortic repair or thoracic endovascular aortic repair. Subclinical malperfusion, defined as imaging evidence only of peripheral malperfusion without resultant severe organ failure, is not an indication for delayed OR. Only when critical organ necrosis and failure are both present and because of dissectionrelated malperfusion with concomitant relative hemodynamic stability (no aortic rupture, no tamponade) can an IR-first approach be beneficial.
Second, there was improvement in patient care in the intensive care unit between the IR procedure and delayed OR. We aggressively pursued anti-impulse therapy for patients with ATAAD with meticulous systolic blood pressure control (goal 90-110 mm Hg) and adequate analgesia and sedation. We recommend against lightening sedation for a neurological examination before the open aortic repair. We kept patients intubated and sedated until OR if we anticipated that the patient would recover from MPS complications and be ready for OR in ≤1 week.
Third, we took patients for OR sooner after IR in the second decade. The median wait time from IR to OR decreased from 4 days to 2 days in the second decade (Table) , including from 7 days to 4 days in the high-risk MPS group (ie, celiac/mesenteric MPS) and 2 days to 1 day in the nonhigh-risk MPS group (ie, no celiac/mesenteric MPS). We waited for absence of ongoing organ (such as bowel, liver, skeletal muscle) necrosis; resolution of metabolic acidosis, shock, and acute respiratory distress syndrome; and whether the patient could clini- 
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cally tolerate cardiopulmonary bypass and circulatory arrest. We did not wait for complete recovery of organ function, such as renal function, to perform OR. Is our approach (IR plus delayed OR) for patients with ATAAD and MPS better than the traditional approach (upfront OR for every patient)? There are several advantages to resolving critical malperfusion first with the IR approach (fenestration/stenting):
(1) Our approach resolves the arterial obstruction immediately and completely with a percutaneous procedure. The average time to resolve dynamic obstruction is 30 minutes. At the end of the procedure, the blood pressure in each visceral branch (celiac, SMA, and renal arteries) and in the iliac arteries is measured to confirm that arterial obstruction has been relieved. Open aortic repair or thoracic endovascular aortic repair can help resolve dynamic malperfusion but not static malperfusion because of the occlusion of aortic branch vessels from dissection and false lumen thrombosis of the branch vessels. Static malperfusion can be completely resolved by an IR approach (fenestration/stenting of the branch vessels). In 135 patients suspected of having MPS, 106 (79%) had fenestration/stenting of aortic branch vessels (Table I in the online-only Data Supplement), and 17 (13%) had additional procedures for true lumen thrombosis of aortic branch vessels, such as thrombolysis and thrombectomy/embolectomy, none of which could be achieved by upfront OR or thoracic endovascular aortic repair. Once the arterial obstruction was corrected and patients recovered from MPS, the operative mortality of open aortic repair was very low (3.7%) (Figures 3 and 4) . (2) Our approach gives borderline operative candidates with MPS time to recover and avoids futile open aortic repair in those who are not salvageable. Patients with MPS are critically ill, and operative mortality has been reported to be as high as 45% [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] if upfront OR is performed with cardiopulmonary bypass and hypothermic circulatory arrest. The IR approach is percutaneous and has less of a hemodynamic insult to the patient than OR but achieves similar goals: to resolve malperfusion (giving patients the chance to recover from organ failure, bowel resection, or amputation), and decrease the risk of open aortic repair. In patients with SMA obstruction and suspected bowel infarction needing laparotomy, up-front angiographic correction of SMA obstruction provides a more reliable intraoperative assessment of margins of bowel viability. For those who do not recover from organ necrosis and failure, an open aortic repair would likely be futile, may consume more resources than a percutaneous procedure alone, and may have a more negative impact on the patient and family both physically and emotionally. (3) Our approach provides favorable short-and longterm survival. Compared with expected mortality as calculated by the Verona model, 28 which is the only model that includes all comers of ATAAD with MPS treated with upfront OR and nonoperatively, the observed in-hospital mortality in all patients and patients with MPS treated with upfront IR was significantly lower than expected (Figures 5  and 6 ). Our observed in-hospital mortality and 30-day mortality in all patients with ATAAD with or without MPS (n=354) were significantly lower than expected mortalities calculated from all 5 models (Figures 5 and 6 ). The observed in-hospital and 30-day mortality in patients with MPS (n=49) treated with upfront IR were not significantly lower than the expected mortalities calculated from the other 4 models (Leipzig-Halifax model, 15 Stockholm model, 16 Penn model, 29 and GERAADA model 30 ). A possible explanation is that those 4 studies excluded patients who were not surgical candidates, such as those who had extensive necrotic bowel or who refused open surgery. In our cohort, we had 19 patients who might be considered "not surgical candidates: 3 had completely dead bowels, 1 refused amputation, 3 had brain death, and 
for 12 patients the family withdrew care after the IR procedure" (see Table V in the online-only Data Supplement). These patients were still included in our in-hospital mortality using our IR-first approach. After patients were treated with upfront IR and recovered from MPS, the operative mortality of OR was 6 to 8 times lower than the expected mortality calculated from all 5 models (Figures 5 and 6) , and the long-term survival (5-year survival: 80%; 10-year survival: 63%) was similar to patients with ATAAD without MPS ( Figure 7C ). In other reports, 9,10 patients with MPS treated with upfront OR had worse long-term survival (5-year survival: 42% to 54%; 10-year survival: 43%) compared to patients without MPS (5-year survival: 56% to 66%; 10-year survival: 46%). The combination of cerebral malperfusion with simultaneous visceral or limb malperfusion is difficult to treat. When patients present with a neurological deficit but without visceral or limb necrosis (MPS), we recommend immediate open aortic repair. If a patient has visceral or limb MPS in addition to a neurological deficit, then we recommend IR fenestration and stenting first and open aortic repair as soon as patients can tolerate the procedure.
Any approach to treat patients with ATAAD and MPS comes with a high risk of complications, including mortality for various reasons. Two (4%) patients with MPS died from aortic rupture, which could have potentially been prevented by upfront OR. However, based on the Penn and GERAADA models, the 30-day operative mortality would have been 26% to 31% for those 2 patients based on their preoperative condition. Surgeons have to balance the 30% risk of operative mortality and the 4% risk of aortic rupture. We would recommend accepting the latter and performing fenestration/stenting first. If patients recover from MPS, then the operative mortality was 4% in our series in the second decade. Taken together, our results support our second hypothesis that endovascular reperfusion through fenestration/stenting as the first intervention before definitive operative repair is more beneficial than upfront open aortic repair in stable patients with ATAAD and MPS.
Our study is limited by being a single-center and retrospective experience. The IR approach has a learning curve, and not every institution has the resources and IR expertise available. In the case of pure dynamic obstruction, fenestration with an aortic true lumen stent is within the toolbox of most interventional radiologists. If an institution cares for patients with aortic dissection on a regular basis, then the interventions should be done with the assistance of intravascular ultrasound. More complicated cases (dynamic plus static obstruction of visceral and iliac vessels, false lumen thrombosis in the SMA, renal arteries, and iliac arteries, etc.) should probably be transferred to a higher volume institution. It was not ideal to compare the outcome of our approach to the models in the literature because we did not know the detailed inclusion and exclusion criteria of other studies. A prospective randomized trial would be ideal to compare those 2 methods. However, given the life-or-death circumstance and critical clinical presentation that accompanies ATAAD with MPS, it would be almost impossible to conduct a randomized prospective trial to compare upfront IR plus delayed OR versus upfront OR. The MPS cases undergoing IR were hemodynamically relatively stable. It is difficult to compare these patients to the literature with MPS in other series (mortality ≤45%) because of unspecified inclusion and exclusion criteria. However, our in-hospital mortality of all comers with MPS (stable or unstable) in the second decade was 29%. We believe our findings could potentially change the standard of care approach for patients with ATAAD and MPS.
In conclusion, for most patients with acute type A aortic dissection, immediate OR remains the recommended approach to prevent death. However, for patients who are relatively stable (no rupture or tamponade) presenting with MPS and significant end-organ dysfunction, a staged approach (upfront endovascular reperfusion by fenestration/stenting followed by delayed open aortic repair at the time of resolution of severe organ failure) may be more beneficial. 
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